2Tillerson JL, Miller GW. Grid performance test to measure behavioral impairment in the MPTP-treated mouse model of Parkinsonism [J]. J Neurosci Methods, 2003, 123 : 189-200.
4Hadj Tahar, Gregoire I, Bangassoro E, et al. Sustained cabergoline treatment reverses levodopa-induced dyskineslas in parkinsonian monkeys[J]. Clin Neuropharmacol, 2000,23(4) : 195- 202.
5Wermuth L. A double-blind, placebo-controlled, randomized, multi-center study of pramipexole in advanced Parkinson's disease[J]. Eur J Neurol,1998,5(3) :235-242.
6Weiner WJ,Factor SA, Jankovic J, et al. The long-term safety and efficacy of pramipexole in advanced Parkinson's disease [J]. Parkinsonism Relat Disord,2001,7(2) :115-120.
7Biglan KM, Holloway RG. A review of pramipexole and its clinical utility in Parkinson's disease[J]. Expert Opin Pharmacother,2002,3(2) :197-210.
9Rabey JM,Sagi I, Huberman M, et al. Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson' s disease: a double blind study as adiunetive therapy to levodopa[J].Clin Neuropharnacol, 2000,23(6) :324-330.
10Calne D,Sehulzer M, Mak E,et al. Treatment for the progression of Parkinson's disease[J].Lancet Neurol, 2005,4(4) 206.
二级参考文献11
1Schaltenbrand G. Wahren W. Atlas for stereotaxy of the human brain. 2nd edition. Stuttgart: Thieme, 1977.
2Alvarez Gonzalez L, Macias R, Guridi J, et al. Lesion of the subthalamic nucleus in Parkinson's disease: long term follow-up.Ann Neurol, 1999, 46:492-493
3Alvarez L, Macias R, Guridi J, et al. Dorsal subthalamotomy for Parkinson's disease. Mov Disord, 2001, 16( 1 ) :72-78
4Lenz FA, Tasker RR, Kwan HC, et al. Single unit analysis of the human ventral thalamus nuclear group: correlation of thalamic "tremor cells" with the 3-6 Hz component of parkinsonian tremor. J Neurosci, 1988, 8: 754-764.
5PA Starr, JL Vitek, RA Bakay. Deep brain stimulation for movement disorders. Neurosurgery Clinics of North America, 1998, 9 (2):381-402.
6MS Okun, JL Vitek. Lesion therapy for Parkinsong disease and other movement disorders: update and controversies. Mov Disord, 2004,19(4) : 375-389.
7Oh MY,Hodaie M,Kim SH,et al.Deep brain stimulator electrodes used for lesioningproof of principle. Neurosurgery, 2001, 49 (2): 363-367.
8Favre J,Burchiel KJ,Taha JM,et al. Outcome of unilateral and bilateral pallidotomy for Parkinson's disease:patient assessment. Neurosurgery,2000, 46 (2): 344-353.
9Dowsey-Limousin P,Pollak P.Deep brain stimulation in the treatment of Parkinson's disease:a review and update. Clin Neurosci Res,2001, 521-526.
